Aurora Spine Corporation (“Aurora Spine”) is pleased to announce that it has filed a final prospectus with the securities regulatory authorities in the provinces of Alberta and Ontario in connection with a proposed initial public offering of 5,150,000 common shares at a price per share of USD$0.70, for total gross proceeds of USD$3,605,000. The offering is being made on a “best efforts” agency basis by M Partners Inc.
Prior to, and in connection with, the offering, Aurora Spine will become the sole stockholder of Aurora Spine, Inc., an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
The majority of the proceeds of the offering will be used to fund costs associated with completing development, testing and launching of Aurora Spine’s second lumbar fusion device.
The final prospectus, which contains important information relating to Aurora Spine and the common shares being offered, may be obtained on SEDAR and is available for review at www.sedar.com.
The offering is expected to close on or about September 4, 2013. Aurora Spine has received conditional listing approval for the listing of its common shares on the TSX Venture Exchange (the “TSXV”) under the symbol “ASG” subject to Aurora Spine fulfilling all of the listing requirements of the TSXV.